To strengthen the development of biomedical translation teams at universities, academic research institutions, and medical institutions nationwide, the National Biotechnology Research Park held the second annual "NBRP Pitch Day" from Monday, September 30th to Tuesday, October 1st.
Pitch Day brings together innovative resources from across the country, serving as a key platform for translational teams to showcase their technologies and creative ideas and rewarding teams with strong commercialization potential.
This event combined biomedical innovation with business partnering activities. KMU's spin-off startup, PrecisemAb Biotech Co., Ltd., and Associate Professor Wen-Wei Lin’s research team participated in the New Drug and Medical Device categories, respectively, and successfully advanced to the finals.
The exhibition content is as follows:
|
No. |
Exhibition Topic 展示內容 |
Representative 技術代表人 |
|
1. |
Universal Antibody Lock 萬能抗體鎖 |
CEO, Yunchi Lu 呂韻綺 執行長 |
|
2. |
DSCE: An Innovative Gene Expression Monitoring System 雙型態呈：色酵素報告基因系統 |
Associate Professor, Wen-Wei Lin 林文瑋 副教授 |
PrecisemAb Biotech Co., Ltd. successfully matched with several venture capital firms. Follow-up discussions will continue after the event with hopes of securing funding. In addition, PrecisemAb Biotech Co., Ltd. was honored with the “Potential Team Award.”
恭賀碩準公司(高醫衍生新創公司)榮獲2024 NBRP Pitch Day 潛力團隊獎!
為了加強全國大專院校、學術研究機構及醫療院所生醫轉譯團隊的發展，國家生技研究園區於09/30(一)至10/01(二) 舉辦第二屆「NBRP Pitch Day」。
Pitch Day匯聚來自全國的創新資源，不僅成為轉譯團隊展現技術和創新理念的重要平臺，亦獎勵具商品化潛力的團隊。
這是一場結合生醫創新與投資媒合的盛會，本校衍生新創團隊－碩準公司與科創團隊－林文瑋副教授團隊分別參加新藥組與醫材組徵選，並成功入圍決賽。
碩準成功與數家創投公司進行媒合，會後將持續追蹤洽談，期望促成團隊成功募得資金，此外，碩準榮獲「潛力團隊獎」殊榮。
